Opus Genetics (IRD) News
NASDAQ: IRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.65+0.19 (+4.26%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
IRD news summary
We found 1 recent headline mentioning Opus Genetics (IRD): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, IRD is up 4.26% at $4.65. The most recent story, "Biotech Stocks Facing FDA Decision In October 2026", was published by Nasdaq on Sep 29, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology